Overview
A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
Status:
Completed
Completed
Trial end date:
2005-11-01
2005-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthmaPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:- Mild to moderate persistent asthma (NAEPP/GINA Step 2-3)
- Reversibility to albuterol at least 12% and 200 mL
Exclusion Criteria:
- Any significant co-morbid disease, particularly cardiovascular
- Use of any maintenance therapy except short acting bronchodilators
- Smoking history > or = 10 years